Cargando…
Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients
OBJECTIVE: Our objective was to assess the pattern of urine infections, the most common pathogen, and their susceptibility pattern to antibiotics among Saudi diabetic patients. METHODS: We performed a year-long cross-sectional study from January 2018 to January 2019 at KAAU Hospital in Riyadh, KSA....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SBDR - Society for Biomedical Diabetes Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044050/ https://www.ncbi.nlm.nih.gov/pubmed/35831935 http://dx.doi.org/10.1900/RDS.2022.18.135 |
_version_ | 1784913278534680576 |
---|---|
author | Al-Mijalli, Samiah Hamad S Shami, Ashwag Y Al-Salem, Rasha A Alnafisi, Nawaf M |
author_facet | Al-Mijalli, Samiah Hamad S Shami, Ashwag Y Al-Salem, Rasha A Alnafisi, Nawaf M |
author_sort | Al-Mijalli, Samiah Hamad S |
collection | PubMed |
description | OBJECTIVE: Our objective was to assess the pattern of urine infections, the most common pathogen, and their susceptibility pattern to antibiotics among Saudi diabetic patients. METHODS: We performed a year-long cross-sectional study from January 2018 to January 2019 at KAAU Hospital in Riyadh, KSA. We cultured the urine specimens obtained from diabetic patients based on optimal aerobic and anaerobic microbiological methods. By adopting standard microbiological methods, we identified the bacterial isolates. We also followed the guidelines of the Clinical and Laborator y Standards Institute (CLSI) to do antibiotic susceptibility testing. RESULTS: A total of 100 isolates were evaluated, and a total of 22 organisms were isolated. The majority were multidrug-resistant organisms. Streptococcus haemolyticus was the most frequent organism and rated (15%). It was followed by Staphylococcus hominis (11%), Pseudomonas aeruginosa (9%), Enterococcus faecalis (9%), Enterococcus fiseum (7%), Escherichia coli (7%), Staphylococcus aureus (7%), Staphylococcus lantus (5%) and Klebsiella pneumoniae (5%). We also found multi-microbial infections. Most of the organisms were susceptible to tigecycline, gentamycin, and nitrofurantoin, rating (88%), (84%) and (78%), respectively. CONCLUSIONS: Our study revealed that a wide range of pathogens affects the diabetes patients. Staphylococcus haemolyticus is the most prevalent pathogen. We observed considerable antimicrobial resistance. Tigecycline had a wide sensitivity spectrum and was effective against most of the bacteria. Thus, it can be used as an empirical antibiotic. |
format | Online Article Text |
id | pubmed-10044050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SBDR - Society for Biomedical Diabetes Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-100440502023-03-29 Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients Al-Mijalli, Samiah Hamad S Shami, Ashwag Y Al-Salem, Rasha A Alnafisi, Nawaf M Rev Diabet Stud Research OBJECTIVE: Our objective was to assess the pattern of urine infections, the most common pathogen, and their susceptibility pattern to antibiotics among Saudi diabetic patients. METHODS: We performed a year-long cross-sectional study from January 2018 to January 2019 at KAAU Hospital in Riyadh, KSA. We cultured the urine specimens obtained from diabetic patients based on optimal aerobic and anaerobic microbiological methods. By adopting standard microbiological methods, we identified the bacterial isolates. We also followed the guidelines of the Clinical and Laborator y Standards Institute (CLSI) to do antibiotic susceptibility testing. RESULTS: A total of 100 isolates were evaluated, and a total of 22 organisms were isolated. The majority were multidrug-resistant organisms. Streptococcus haemolyticus was the most frequent organism and rated (15%). It was followed by Staphylococcus hominis (11%), Pseudomonas aeruginosa (9%), Enterococcus faecalis (9%), Enterococcus fiseum (7%), Escherichia coli (7%), Staphylococcus aureus (7%), Staphylococcus lantus (5%) and Klebsiella pneumoniae (5%). We also found multi-microbial infections. Most of the organisms were susceptible to tigecycline, gentamycin, and nitrofurantoin, rating (88%), (84%) and (78%), respectively. CONCLUSIONS: Our study revealed that a wide range of pathogens affects the diabetes patients. Staphylococcus haemolyticus is the most prevalent pathogen. We observed considerable antimicrobial resistance. Tigecycline had a wide sensitivity spectrum and was effective against most of the bacteria. Thus, it can be used as an empirical antibiotic. SBDR - Society for Biomedical Diabetes Research 2022-06-30 /pmc/articles/PMC10044050/ /pubmed/35831935 http://dx.doi.org/10.1900/RDS.2022.18.135 Text en Copyright © by Lab & Life Press https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 Unported (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Research Al-Mijalli, Samiah Hamad S Shami, Ashwag Y Al-Salem, Rasha A Alnafisi, Nawaf M Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients |
title | Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients |
title_full | Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients |
title_fullStr | Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients |
title_full_unstemmed | Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients |
title_short | Development of Diagnostic Capabilities for Complications of Bacterial Infection in Diabetic Patients |
title_sort | development of diagnostic capabilities for complications of bacterial infection in diabetic patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044050/ https://www.ncbi.nlm.nih.gov/pubmed/35831935 http://dx.doi.org/10.1900/RDS.2022.18.135 |
work_keys_str_mv | AT almijallisamiahhamads developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients AT shamiashwagy developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients AT alsalemrashaa developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients AT alnafisinawafm developmentofdiagnosticcapabilitiesforcomplicationsofbacterialinfectionindiabeticpatients |